|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US7858118||CIPHER PHARMS INC||Extended release composition containing Tramadol|| |
(1 year, 5 months ago)
Conzip is owned by Cipher Pharms Inc.
Conzip contains Tramadol Hydrochloride.
Conzip has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Conzip are:
Conzip was authorised for market use on 07 May, 2010.
Conzip is available in capsule, extended release;oral dosage forms.
Conzip can be used as use of tramadol for the management of moderate to moderately severe chronic pain.
The generics of Conzip are possible to be released after 11 April, 2022.
Market Authorisation Date: 07 May, 2010
Treatment: Use of tramadol for the management of moderate to moderately severe chronic pain
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic